Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2003
08/21/2003WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders
08/21/2003WO2003068161A2 Composition and method for protecting labile active components
08/21/2003WO2003068152A2 Purified cytokine inhibitory factor
08/21/2003WO2003068149A2 Preparations of nucleus pulposus cells and methods for their generation, identification, and use
08/21/2003WO2003067991A1 Compositions and methods for treatment of microbial infections
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003027245B1 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
08/21/2003WO2003024471A3 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002067861A3 Oncolytic adenoviral vectors
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002036141A3 Method of enhancing lymphocyte-mediated immune responses
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001090342A3 Genetic engineering of vascular grafts to resist disease
08/21/2003WO2001010453A3 Bifidobacteria capable of preventing diarrhea
08/21/2003US20030159158 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders
08/21/2003US20030158248 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide
08/21/2003US20030158123 Purified material having size and growth inhibitory effects on cells and tissues
08/21/2003US20030158122 For treatment of hyperlipidemia and blood coagulation disorders and to reduce levels of virus, bacteria, and endotoxins in blood stream
08/21/2003US20030158113 Administering to individual a therapeutically effective amount of osteopontin or a functional fragment
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158086 For use in therapy ofweak immunity and immunodeficiencies, hormonal disorders, as a nutrient for skin, hair, nails, in food supplements, cosmetics
08/21/2003US20030157718 Expression of heterologous genes from an IRES translational cassette in retroviral vectors
08/21/2003US20030157713 Anchorage-dependent cell for propagating and measuring cytotoxic activity of lymphocyte; antitumor agents
08/21/2003US20030157711 STAT3 activated stem cell
08/21/2003US20030157707 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
08/21/2003US20030157474 Removal antigens from blood
08/21/2003US20030157473 Compositions comprising reproductive cell media and methods for using such compositions
08/21/2003US20030157198 Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity
08/21/2003US20030157164 Comprises probiotic microorganisms (lactic acid producing bacteria) and oligosaccharides (fructose, inulin), for normalizing/balancing bacterial flora present in the stomach and intestines
08/21/2003US20030157140 Parenteral preparation having structure of basement polymer layer, carrying layer containing objective substances selected from drugs, aroma chemicals, antigens; carrying layer sandwiched between basement and surface layers
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157131 Interferon inducing genetically engineered attenuated viruses
08/21/2003US20030157130 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging
08/21/2003US20030157128 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157114 Treatment of autoimmune diseases
08/21/2003US20030157102 Administering a ligand having a population of activated t cells and binding specificity for the extracellular domain of CD28 to enhance t cell proliferation and increase overall lymphokine levels
08/21/2003US20030157094 Prevention, therapy liver disorders, inflammatory bowel diseases, Crohn's disease; antiulcer agents; rheumatic diseases
08/21/2003US20030157089 Polypeptides; inducting immunology response
08/21/2003US20030157080 Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine erythrocyte preparations
08/21/2003US20030157079 Adhesion to mucous membranes; cell proliferation; prevention, therapy of digestion diseases
08/21/2003US20030157078 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
08/21/2003US20030157077 Induction of chimera mixture; anticancer agents, leukemia
08/21/2003US20030157073 Methods for pretreating a subject with apoptotic cells
08/21/2003US20030157071 Hormone replacement therapy; transduction bone marrow cells; cell differentiation
08/21/2003US20030157067 Mixture of bacteria culture product, sugar, carrier and flavor
08/21/2003US20030157064 Actin gene promoter; genetic engineered polypeptide; cardiovascular disorders
08/21/2003US20030157060 Production of tcr gamma delta t cells
08/21/2003US20030157057 Antiinflammatory agents, antitumor agents, autoimmune disease
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2476553A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003CA2476530A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003CA2476126A1 Shark cartilage extracts and use thereof for immunomodulation
08/21/2003CA2474360A1 Purified cytokine inhibitory factor
08/21/2003CA2471392A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/20/2003EP1336654A1 Method of treating psoriasis using anti-gamma interferon antibody
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335972A2 Tolerizing allografts of pluripotent stem cells
08/20/2003EP1335739A2 Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
08/20/2003EP1335737A2 Method for optimally delivering virus to a solid tumor mass
08/20/2003EP1335736A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders
08/20/2003EP1335735A1 Vascularised tissue graft
08/20/2003EP1189908B1 Indolocarbazole alkaloids from a marine actinomycete
08/20/2003EP1032268A4 Reduced antigenic cells and uses therefor
08/20/2003EP0865288B1 Bioartificial devices and cellular matrices therefor
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003CN1437654A Antigenic proteins of shrimp white spot syndrome virus uses thereof
08/20/2003CN1437634A The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use
08/20/2003CN1437475A Combined cartilage and plant extract composition
08/20/2003CN1436843A Making process of umbilical hemopoietic stem cell
08/20/2003CN1436571A Thrombosis resisting composition
08/20/2003CN1436564A Liver cancer treating medicine and its prepn
08/20/2003CN1436561A Externally applied ointment for treating prostatosis and its prepn
08/20/2003CN1436558A Plaster for treating pain and swelling
08/20/2003CN1436541A Diabetes treating medicine
08/20/2003CN1436539A Efficient Fe-Zn-Ca health product for nourishing blood and replenishing calcium and its production process
08/20/2003CN1436538A Effervescent pearl calcium tablet and its prepn process
08/20/2003CN1118297C Chinese patent medicine for treating rheumatic hyperosteogeny and its preparing process
08/20/2003CN1118294C Preparation of medicine fo treating stomach diseases
08/20/2003CN1118292C Medicine for quickly dropping drug
08/20/2003CN1118290C Chinese herb medicine preparaiton for hair growth
08/20/2003CN1118289C Health product for improving sleep
08/20/2003CN1118288C Plaster for treating osteomyelitis and trauma
08/20/2003CN1118285C Plaster for treating wind-cold arthritis with fixed pain caused by dampness
08/20/2003CN1118280C Bioactive concentrate, its producing method and certain medicinal composition containing chondroitin sulphate also
08/20/2003CA2372744A1 A method for extraction and purification of cartilage type proteoglycan
08/19/2003US6608037 TCF responsive element
08/19/2003US6608029 Reducing gastric motility or delaying gastric emptying in mammal by administering therapeutically effective amount of amylin or amylin agonist, such as pramlintide or pramlintide acetate
08/19/2003US6607905 Lactobacillus acidophilus CNCM/I-1492; Lactobacillus casei; cholesterol blood level reduction; dairy products; yogurt; use in production of dairy products and reducing cholesterol levels in blood of mammals
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607743 Milk-derived basic cystatins or decomposition products; foods, beverages, feeds
08/19/2003US6607723 Removing preformed antibodies to various identified carbohydrate xenoantigens from recipient's circulation prior to transplantation by extracorporeal perfusion
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/19/2003US6607720 Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction
08/19/2003US6607501 Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
1 ... 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 ... 1259